MAY 2 0 2002
Ko20 P44
510(k) Summary
IRIDEX® Corporation
Apex® 800 Dermatology Laser System
Submitter’s Name, Address, Telephone Number, Contact Person and Date Prepared
IRIDEX Corporation
1212 Terra Bella Avenue
Mountain View, CA 94043
Contact Person: John D’ Angelo
(650) 962-8848 ext. 3905
Date Prepared: March 11, 2002
Device Information
Trade Name: Apex 800 Dermatology Laser System
Classification Name: Laser Instrument, Surgical, Powered
CFR Section: 878.4810.
Product Code: GEX.
Equivalent Devices
The Apex 800 Laser System is substantially equivalent in intended use and
technological characteristics to other currently legally marketed dermatology laser
devices including the IRIDERM Apex 800 (K992298), the Coherent LightSheer
(K003614), the Cynosure Apogee — TKS and Photogenica DL Laser Systems
(K992757 and K010005) and the Palomar SLP 1000 (K013028).
Device Description
The Apex 800 is a semiconductor diode laser system that delivers pulsed infrared
800 nm laser light.
Intended Use
The IRIDEX Apex 800 Laser System is indicated for hair removal and permanent hair
reduction on all skin types (Fitzpatrick skin types I-VI), including tanned skin; for the
treatment of pseudofolliculitis barbae; for the treatment of vascular lesions including
angiomas, hemangiomas, telangiectasia; for the treatment of leg veins; and for the
treatment of benign pigmented lesions.
Conclusion
The Apex 800 is substantially equivalent to the identified predicate devices.
Page 1

: wees . . : . . : .
f Ka DEPARTMENT OF HEALTH & HUMANSERVICES Public Health Service
3 ad . . . Lo : : :
"se Food and Drug Administration
: 9200 Corporate Boulevard /
. : . - : Rockville MD 20850
Mr. John D'Angelo - se oO MAY 2 0 2002. :
Vice President, Regulatory Affairs : - Se, : ,
and: Quality Assurance a : ,
, IRIDEX Corporation . . a
1212 Terra Bella Avenue
Mountain View, CA 94043 :
Re: K020849
Trade/Device Name: Apex 800 Dermatology Laser System
Regulation Number: 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: March 11, 2002
Received: March 15, 2002
Dear Mr. D'Angelo:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class TIT (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. John D'Angelo .
: ‘This letter will allow you to begin marketing your device as described in your Section S10(k).
- premarket notification. The FDA finding of substantial equivalence of your device.to a legally ~~ - :
__.marketed predicate device results in a classification for your device and thus, permits your device :
: - to proceed to. the market. ‘ Se

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of
Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the
regulation entitled, "Misbranding by reference to premarket notification” (21CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the
Division of Small Manufacturers, International and Consumer Assistance at its toll-free number
(800) 638-2041 or (301) 443-6597 or at its Internet address
http://www.fda.gov/cdrh/dsma/dsmamain.htm]

Sincerely yours,

Murconr C. Gover!

£o/ Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

. . , uO : Page__I of] ,
- - , sO INDICATIONS FOR USESTATEMENT . : .
. 510(k) Number (if known): Boweing KeO2d 2 SF ‘ . .
a ‘Device Name: Ap ex® 800 Dermatology Laser System : ; : SO
' Indications For Use: :

The IRIDEX® Apex 800 Laser System is indicated for hair removal and permanent hair

reduction on all skin types (Fitzpatrick skin types I-VI), including tanned skin; for the

treatment of pseudofolliculitis barbae; for the treatment of vascular lesions including

angiomas, hemangiomas, telangiectasia; for the treatment of leg veins; and for the

treatment of benign pigmented lesions.

(PLEASE DO NOT WRITE BELOW THIS LINE — CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
(@ivision Sign-Of)
Division of General, Restorative
and Neurological Devices
510(k) Number K 0205
Prescription Use f ™ OR Over-The-Counter Use
(Per 21 CFR 801.109)

